Cite
HARVARD Citation
Aranda, E. et al. (n.d.). 2122 Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The MACRO-2 trial. European journal of cancer. pp. S371-S372. [Online].